Targeting tumor-associated macrophages for cancer immunotherapy

被引：98

作者：

Shu, Yongheng ^{[1
,2
]}

Cheng, Ping ^{[1
,2
]}

机构：

[1] Sichuan Univ, West China Hosp, State Key Lab Biotherapy, 17 Peoples South Rd, Chengdu 610041, Peoples R China

[2] Sichuan Univ, West China Hosp, Collaborat Innovat Ctr Biotherapy, Canc Ctr, Chengdu 610041, Peoples R China

来源：

BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER | 2020年 / 1874卷 / 02期

基金：

中国国家自然科学基金;

关键词：

Tumor; Immunotherapy; Tumor-associated macrophages (TAMs); HUMAN MONOCLONAL-ANTIBODY; CHEMOKINE LIGAND 2; CARLUMAB CNTO 888; CAR-T-CELLS; ANTITUMOR-ACTIVITY; SIRP-ALPHA; PHASE-I; MYELOID CELLS; RECEPTOR; ACTIVATION;

D O I：

10.1016/j.bbcan.2020.188434

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

Macrophages are important effector cells of the innate immune system and are also major components of the tumor microenvironment (TME). Macrophages that are abundant in the TME are called tumor-associated macrophages (TAMs). As TAMs promote strong tumor angiogenesis and support tumor cell survival, they are closely related to tumor growth. Several studies have demonstrated that reducing the density or effects of TAMs can inhibit the growth of tumors, making them targets for cancer immunotherapy, which has become a research hot spot. Several clinical and preclinical trials have studied drugs that inhibit the effects of and reduce the population of phagocytes that target TAMs achieve cancer immunotherapy. In this paper, we summarize the various methods of targeting TAMs for tumor immunotherapy, focusing on TAM mechanisms, sources, and polarization.

引用

页数：11

共 123 条

[41] In Vitro Evaluation of Inhibitory Effect of Nuclear Factor-KappaB Activity by Small Interfering RNA on Pro-tumor Characteristics of M2-Like Macrophages [J].

Kono, Yusuke ;

Kawakami, Shigeru ;

Higuchi, Yuriko ;

Yamashita, Fumiyoshi ;

Hashida, Mitsuru .

BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2014, 37 (01) :137-144

[42] Toll-like Receptor 9 Activation of Signal Transducer and Activator of Transcription 3 Constrains Its Agonist-Based Immunotherapy [J].

Kortylewski, Marcin ;

Kujawski, Maciej ;

Herrmann, Andreas ;

Yang, Chunmei ;

Wang, Lin ;

Liu, Yong ;

Salcedo, Rosalba ;

Yu, Hua .

CANCER RESEARCH, 2009, 69 (06) :2497-2505

[43] CD45 Phosphatase Inhibits STAT3 Transcription Factor Activity in Myeloid Cells and Promotes Tumor-Associated Macrophage Differentiation [J].

Kumar, Vinit ;

Cheng, Pingyan ;

Condamine, Thomas ;

Mony, Sridevi ;

Languino, Lucia R. ;

McCaffrey, Judith C. ;

Hockstein, Neil ;

Guarino, Michael ;

Masters, Gregory ;

Penman, Emily ;

Denstman, Fred ;

Xu, Xiaowei ;

Altieri, Dario C. ;

Du, Hong ;

Yan, Cong ;

Gabrilovich, Dmitry I. .

IMMUNITY, 2016, 44 (02) :303-315

[44] RETRACTED: Inflammatory Molecule, PSGL-1, Deficiency Activates Macrophages to Promote Colorectal Cancer Growth through NFκB Signaling (Publication with Expression of Concern. See vol. 18, pg. 939, 2020) (Retracted Article) [J].

Li, Jiangchao ;

Zhou, Zeqi ;

Zhang, Xiaohan ;

Zheng, Li ;

He, Dan ;

Ye, Yuxiang ;

Zhang, Qian-Qian ;

Qi, Cui-Ling ;

He, Xiao-Dong ;

Yu, Chen ;

Shao, Chun-Kui ;

Qiao, Liang ;

Wang, Lijing .

MOLECULAR CANCER RESEARCH, 2017, 15 (04) :467-477

[45] TMEM203 is a binding partner and regulator of STING-mediated inflammatory signaling in macrophages [J].

Li, Yang ;

James, Sharmy J. ;

Wyllie, David H. ;

Wynne, Claire ;

Czibula, Agnes ;

Bukhari, Ahmed ;

Pye, Katherine ;

Mustafah, Seri Musfirah Bte ;

Fajka-Boja, Roberta ;

Szabo, Eniko ;

Angyal, Adrienn ;

Hegedus, Zoltan ;

Kovacs, Laszlo ;

Hill, Adrian V. S. ;

Jefferies, Caroline A. ;

Wilson, Heather L. ;

Zhang Yongliang ;

Kiss-Toth, Endre .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2019, 116 (33) :16479-16488

[46] Simultaneous blocking of CD47 and PD-L1 increases innate and adaptive cancer immune responses and cytokine release [J].

Lian, Shu ;

Xie, Ruizhi ;

Ye, Yuying ;

Xie, Xiaodong ;

Li, Shuhui ;

Lu, Yusheng ;

Li, Bifei ;

Cheng, Yunlong ;

Katanaev, Vladimir L. ;

Jia, Lee .

EBIOMEDICINE, 2019, 42 :281-295

[47] TTI-621 (SIRPαFc), a CD47-blocking cancer immunotherapeutic, triggers phagocytosis of lymphoma cells by multiple polarized macrophage subsets [J].

Lin, Gloria H. Y. ;

Chai, Vien ;

Lee, Vivian ;

Dodge, Karen ;

Truong, Tran ;

Wong, Mark ;

Johnson, Lisa D. ;

Linderoth, Emma ;

Pang, Xinli ;

Winston, Jeff ;

Petrova, Penka S. ;

Uger, Robert A. ;

Viller, Natasja N. .

PLOS ONE, 2017, 12 (10)

[48] Oligodeoxynucleotide CpG 7909 delivered as intravenous infusion demonstrates immunologic modulation in patients with previously treated non-Hodgkin lymphoma [J].

Link, Brian K. ;

Ballas, Zuhair K. ;

Weisdorf, Daniel ;

Wooldridge, James E. ;

Bossler, Aaron D. ;

Shannon, Mary ;

Rasmussen, Wendy L. ;

Krieg, Arthur M. ;

Weiner, George J. .

JOURNAL OF IMMUNOTHERAPY, 2006, 29 (05) :558-568

[49] CAR-T cells and allogeneic hematopoietic stem cell transplantation for relapsed/refractory B-cell acute lymphoblastic leukemia [J].

Liu, Jun ;

Zhang, Xi ;

Zhong, Jiang F. ;

Zhang, Cheng .

IMMUNOTHERAPY, 2017, 9 (13) :1115-1125

[50] The molecular mechanisms of TLR-signaling cooperation in cytokine regulation [J].

Liu, Qian ;

Ding, Jeak Ling .

IMMUNOLOGY AND CELL BIOLOGY, 2016, 94 (06) :538-542

← 1 2 3 4 5 6 7 8 9 10 →